Is Allegra safe during pregnancy?

There's no definitive answer, because fexofenadine (Allegra) hasn't been studied in controlled human pregnancy trials. Available observational data on antihistamines as a class haven't shown a clear pattern of harm, but Allegra-specific pregnancy safety data are more limited than for some older antihistamines. Many providers consider it a reasonable option when allergy symptoms are significant, but the decision depends on your trimester, symptom severity, and personal history. Confirm with your OB-GYN or midwife before starting or continuing it.

No antihistamine is formally proven completely safe during pregnancy, as it is generally unethical to run clinical trials in pregnant women. Chlorpheniramine and loratadine have a longer human use history and are sometimes preferred by providers based on that record. However, this is a decision for your OB-GYN, not a self-directed one. Your provider will weigh your trimester, symptom severity, and available alternatives.

Allegra-D combines fexofenadine with pseudoephedrine, a decongestant that's generally treated with more caution during pregnancy, especially in the first trimester, due to its effect on blood vessels. Many providers prefer avoiding pseudoephedrine-containing products like Allegra-D in early pregnancy and may suggest plain Allegra or a saline nasal rinse for congestion instead. Whether Allegra-D is appropriate for you, and at which trimester, is a decision only your OB-GYN can make based on your specific situation.

Under the older FDA letter system, fexofenadine (Allegra) was classified as Pregnancy Category C, meaning animal studies showed some risk or weren't conclusive, and adequate human studies were lacking. The FDA replaced letter categories with narrative pregnancy and lactation labeling in 2015, so current Allegra labeling describes available data in sentences rather than a single letter. Either way, a category or label summary doesn't replace an individualized discussion with your OB-GYN about your specific symptoms and trimester.

Severe allergy symptoms can disrupt sleep, worsen asthma (if present), and reduce quality of life — all of which have indirect effects during pregnancy. This is one reason why your provider may sometimes recommend a medication over doing nothing. The decision is a risk-benefit discussion, not a simple yes or no. Please discuss your specific situation with your OB-GYN.

The first trimester is generally when medication avoidance is most cautious, as major organ development occurs. Whether any antihistamine — including Allegra — is appropriate in the first trimester is a question specifically for your OB-GYN or midwife. Do not make this decision based on general online information.

Generally, allergists allow patients to continue a maintenance-dose allergy shot regimen they were already tolerating well before pregnancy, since stopping can cause symptoms to flare. Starting a brand-new immunotherapy course or increasing doses during pregnancy is typically avoided, because the risk of a systemic allergic reaction during up-dosing is a greater concern while pregnant. Every patient's situation differs, so this should be managed jointly by your allergist and OB-GYN rather than decided on your own.

Fexofenadine passes into breast milk in small amounts, similar to other antihistamines, though significant effects on breastfed infants haven't been well established. Some providers prefer loratadine or cetirizine while breastfeeding based on a longer safety track record, while others consider Allegra an acceptable option. As with pregnancy, this decision should be made with your OB-GYN, midwife, or pediatrician rather than based on general information.